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| BACKGROUD
Familial adenomatous polyposis (FAP) is a hereditary colorectal cancer (CRC) syndrome caused by pathogenic germline variants of the adenomatous polyposis coli (APC) tumor suppressor gene located on chromosome 5(5q21-22;OMIMNM_000038.5). FAP is characterized by the development of hundreds to thousands of adenomatous polyps in the colon and rectum. The global prevalence of FAP is estimated at 3 cases/100,000 people; the prevalence in Brazil is 1 case/30,000 people. [1] [2] [3] FAP patients exhibit different phenotypes and the associated extracolonic manifestations vary considerably. The incidence of extracolonic manifestations is as high as 40%. For many decades, CRC was the main cause of death among FAP patients; however, this is changing due to a more thorough understanding of the disease, early diagnosis, and prophylactic surgery. Currently, desmoids tumors and upper gastrointestinal tumors are the main causes of death and therefore these tumors require long-term monitoring. 4 In general, all patients with pathogenic germline variants of APC develop adenomas by age 35. Progression into CRC on average starts in one or more adenomas at age 39 and 95% of patients are affected by age 50. However, approximately 7% of patients develop CRC soon after the age of 20. 5 Extracolonic manifestations differ according to the genotype. Upper gastrointestinal lesions, such as duodenal adenomatous polyps occur in up to 90% of cases. Duodenal papillary or periam pullary polyps develop in up to 50% of cases. The risk of an FAP patient developing periam pullary carcinomas and duodenal or papillary carcinoma is increased 100-fold to 300-fold compared to that of the overall population. The development of brain tumors in FAP patients is known as Turcot syndrome, while Gardner syndrome is the association of FAP with duodenal periam pullary adenomas, congenital hypertrophy of the retinal pigment epithelium (CHRPE), jaw osteomas, odontomas, desmoid tumors, thyroid tumors, and biliary duct tumors. 5, 6 Desmoid tumors occur in up to 30% of FAP cases and are associated with high morbidity. Risk factors for the occurrence of desmoid tumors include positive family history, being female, previous abdominal surgery, and APC pathogenic variants at codon 1309. 7 All index patients and participating relatives who signed the informed consent for the trial participation were analyzed in this study. The authors confirm that all ongoing and related trials for this intervention are registered. All procedures performed in this study were in accordance with the ethical standards of the institutional research committee, and with the 1964 Helsinki declaration and its later amendments. Patients diagnosed with classic FAP and carriers of pathogenic germline variants of APC were included. Patients were subjected to directed clinical interviews including personal and family history of CRC and extracolonic manifestations, genogram plotting, physical examination, and genetic counseling prior to and following genetic testing.
| Testing protocol
FAP staging was performed based on colonoscopy and anatomic-pathological examination according to the InSIGHT Polyposis Staging System (IPSS). 9 The following seven extracolonic manifestations were assessed by specific tests: intervention, imaging, and endoscopic exams were routinely performed each year. A brain MRI was performed every 3 years for patients with no abnormal findings.
| Families and patients
A total of 35 families with pathogenic variants of APC were assessed and a total of 99 individuals received follow-up at Barretos Cancer Hospital (BCH). The genotype-phenotype correlation was assessed for all participants.
| APC gene analysis
The genetic tests were performed at the BCH Center of Molecular Diagnosis using DNA extracted from peripheral blood. All encoding exons and flanking intronic regions were amplified by polymerase chain reaction (PCR) and subjected to conventional bidirectional sequencing (Sanger method) using the ABI3500xL platforms described by Palmero et al. 10 The primers for amplification were designed and validated by the technical-scientific staff of the BCH Center of Molecular Diagnosis. Sequencing was performed using a BigDyeTerminatorv3.1Cycle Sequencing Kit (Life Technologies). The electropherograms were analyzed using SeqScape software (Applied Biosystems). All samples with possible deleterious variants were re-extracted and subjected to a second PCR amplification followed by bidirectional sequencing of the involved region. Family members tested for pathogenic variants previously identified in the index case were included for genetic testing targeting the variant segregated within the family. All identified variants were graded based on their deleterious potential and clinical effect using the Leiden Open Variation Database (LOVD Colon Cancer Gene Variant Databases), Human Genome Variant Database (HGMD), and ClinVar database.
| Statistical analysis
The data were subjected to descriptive statistics; analysis was performed using SPSS V19.
| RESULTS
A total of 99 individuals with FAP from 35 families with pathogenic germline variants of APC were analyzed. Table  1 describes the families included in the study and the APC variants identified. In total, 26 different pathogenic germline variants in APC were identified and family #12 exhibited two different pathogenic variants. Table 2 describes the patient staging according to IPSSColon 9 . Thirty-five patients were characterized as stage 4
that included 29 cases of adenocarcinoma and 6 cases of high-grade carcinoma. Characteristics of the residual rectal polyps of patients subjected to prophylactic surgery with rectal preservation are described in Table 3 . Eighty-one of the 99 individuals analyzed were subjected to colon surgery for which rectal preservation was attained in 53 of the patients. Two cases categorized as stage 4 exhibited high-grade dysplasia. These 2 cases were from the same family with variant p.Glu1309Aspfs*4 (c.3927_3931delAAAGA). Another case that had variant p.Ser1104Glufs*19 (c.3310_3316delTCAC-GGG) exhibited recurrence of rectal adenocarcinoma. The study cohort included 50 female patients (50.5%), and 49 male patients (49.5%). The patient ages ranged from 12 to 67 years old. The mean age was 30.7 years old and the median age was 29 years old. The classic polyposis phenotype was identified in 94 cases (94.9%); the other 5 cases (5.1%) exhibited a highly aggressive profuse phenotype. Four of the 5 had pathogenic variants in exon 15, and one had a pathogenic variant in exon 7 (Table 4 ). All 5 cases of highly aggressive profuse phenotype were in male patients.
Fifty-five (55.6%) of the pathogenic variants were nonsense and 39 (39.4%) were frameshift. Three (3%) of the variants were rearrangements and 1 (1%) was a splicing error. In 1 of the 35 families, 2 different pathogenic variants were identified, including 1 nonsense and 1 rearrangement that involved a heterozygous deletion of the entire APC (1%). These 2 variants were identified in 3 family members. The characteristics of family #12 are detailed in Table 5 .
The protocol tests did not reveal any evidence of cancer in 63 of the patients (63.6%). Among the 36 (36.4%) patients with cancer, 29 (80.6%) had CRC, 4 (11.2%) had thyroid cancer, 2 (5.5%) had stomach cancer, and 1 (2.7%) had brain cancer. The characteristics of the molecular abnormalities detected in APC among the cancer patients are described in Table 6 .
Family #9 contributed the largest number of patients analyzed from a single family (n = 13). One male member was diagnosed with a brain tumor. This individual harbored the variant p.Tyr986Ter (c.2958T>G) in exon 15. At age 14 years, he was subjected to craniotomy for resection of a medulloblastoma and placement of a ventricular shunt. Seven years later, he underwent prophylactic colon surgery that included video laparoscopic total colectomy with ileorectal anastomosis. He also exhibited multiple low-grade duodenal adenomas, which were also located on the papilla. These lesions were treated by serial resections via upper gastrointestinal endoscopy (UGIE).
Four female patients were diagnosed with papillary thyroid carcinoma. Two of the patients were members of family #2 and had the p.Arg213Ter(c.637C>T) variant in exon 5. The other 2 patients were unrelated from families #1 and #29 and each 
T A B L E 3 InSIGHT Polyposis Staging
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exhibited the same variant, p.Gln1062Ter(c.3183_3187delA-CAAA) in exon 15. Stomach cancer without an association with CRC was diagnosed in 2 individuals from different families; each had a pathogenic variant in exon 15. One patient was a 43-yearold male from family #9, had the p.Tyr986Ter(c.2958T > G) variant, and also exhibited a mesenteric desmoid tumor. The other patient was a 42-year-old female from family #13 who had the p.Tyr1166Ter(c.3498T>A) variant.
We identified 1 case with a de novo pathogenic variant. This patient was a 15-year-old female from family #20 with the classic polyposis phenotype and a p.Gln1328Ter(c.3982C>T) variant in exon 15. This patient exhibited low-grade adenomatous polyps in the colon and rectum, and adenomas with low-grade dysplasia in the stomach, duodenum, and duodenal papilla, which were removed by serial resection via UGIE.
The genotype-phenotype correlations for extracolonic manifestations are detailed in Table 7 . Nine cases had desmoid tumors: 1 case with a pathogenic variant in exons 5, 7, and 8 and 6 cases with a variant in exon 15. Among the latter, 3 patients were members of family #9 and had the p.Tyr986Ter(c.2958T>G) variant. Ten cases of osteoma were diagnosed. Three of these patients were from family #2 and harbored a p.Arg213Ter(c.637C>T) variant in exon 5. The other 7 osteoma patients were from different families and had pathogenic germline variants in codons 232, 283, 302, 554, 713, 1062, and 1309. Nine cases of CHRPE were diagnosed that included 7 patients from family #1 that had the p.Gln1062*(c.3183_3187delACAAA) variant in exon 15. The eighth case was a patient with a p.Arg805Ter(c.2413C>T) pathogenic variant in exon 15 and the ninth case had a p.Arg232Ter(c.794C>T) variant in exon 7.
| DISCUSSION
The genotype-phenotype correlations of pathogenic germline variants of the APC have been thoroughly studied; however, the available data were primarily derived from Europe, North America, and Asia. Little information for Latin America is available despite the fact that the first pathogenic variant in the APC in Brazil was detected in 1994 and published in 1998. (codon 1309-c.3956delC ). This variant has been frequently described in Japanese studies but not in Brazilian studies. In the southern and south eastern regions of Brazil, this variant is noted in only 9% of FAP cases. 13 To the best of our knowledge, this study is the largest Brazilian case series analyzed to date. This study is also the first prospective Brazilian study to investigate the correlation with 7 different phenotypes with their corresponding genotypes. Twenty-six different pathogenic variants in the APC were identified. Consistent with reports in the literature, the largest proportion of our case series involved classic FAP (94.9%). Most of the classical FAP cases corresponded to nonsense and frameshift pathogenic variants and exhibited wide variability in their distribution across exons. The pathogenic variants predominantly involved exons 5, 8, and 15 and 1 case involved a complete deletion of exons 1 through 15. According to the literature, most cases of FAP with the profuse phenotype exhibit a variant in exon 15. In 60% of the cases, the variant is located between codons 1250 and 1556. The most aggressive phenotypes are seen in carriers of pathogenic variants in codon 1309 and include an earlier appearance of profuse polyposis symptoms, a high risk of CRC at an early age, and the occurrence of associated desmoid tumors. In this study, 5 cases exhibited the profuse FAP phenotype, which involved codon 232 of exon 7 and codons 805, 1062, 1104, and 1309 of exon 15. Concordance was related to the aggressiveness of variant in codon 1309. Three families including 8 individuals in total exhibited variant in codon 1309. Three of these patients exhibited CRC. One of these patients was diagnosed at age 17 and also developed colon cancer, jaw osteoma, "in situ" duodenal papillary cancer, and IPSSRectum stage 4 adenomas. Another individual, a 34-year-old patient with IPSS-Rectum stage 4 adenomas, underwent serial proctosigmoidoscopy for polyp resection. To date, the remainder of this group has not exhibited any other phenotypic manifestation, except for gastric and duodenal adenomatous polyps with low-grade dysplasia. 14, 15 This study detected a substantially aggressive characteristic involving rectal tumor development in a patient from family #8 with profuse FAP and a variant in exon 15 at codon 1104. This patient underwent surgery with rectal preservation for the treatment of polyposis and colon cancer. Unfortunately, 1 year later, he developed a rectal tumor with peritoneal carcinomatosis and died. The literature describes a correlation for intermediate phenotypes of extracolonic manifestations and less than 1000 colonic polyps with this genetic region. 14 We consider pathogenic variants in codons 1104 and 1309 as being highly relevant for the early appearance of FAP symptoms, the development of disease at a young age, and an increased risk for CRC. Because of this, rectal preservation should be carefully assessed during prophylactic surgery among carriers of variants in codons 1104 and 1309.
T A B L E 4 Characteristics of FAP patients from different families with the profuse phenotype
Regarding type 2 brain tumor polyposis (BTP), 1 case of medulloblastoma occurred in a 14-year-old patient with low-grade colonic, duodenal, and papillary adenomas and a variant in exon 15 at codon 986. This finding was consistent with reports in the literature that describe a relationship between this type of tumor and variants between codons 686 and 1217. 16 In this study, the p.Tyr986Ter(c.2958T>G) variant was associated with the occurrence of gastric cancer and desmoid tumors. Thus, carriers of this pathogenic variants require regular monitoring of the upper gastrointestinal tract by means of UGIE and annual CT screenings for desmoid tumors. Prophylactic surgery of the colon for prevention of desmoid tumors is recommended starting at age 25 or later. Among thyroid tumors, the histological type most frequently described in the literature is papillary thyroid carcinoma (PTC). PTC is more frequent among women, which was also the situation in this study. A relationship has been described between PTC and CHRPE when the pathogenic variants involve codons 463-1387; however, these disorders are not associated when the pathogenic variants involve codons 1220-1513. 17 We detected 4 cases of PTC among females in this study with 2 of the cases being from the same family with a variant in exon 5 at codon 213. The other 2 cases involved unrelated patients that had the same variant in exon 15 at codon 1062, did not exhibit an association with CHRPE, but did exhibit duodenal and papillary adenomas and craniofacial osteomas. Based on these findings, patients with pathogenic variants in exons 5 and 15 of APC, specifically the p.Arg213Ter(c.637C>T) variant in codon 213 and the p.Gln1062*(c.3183_3187delACAAA) variant in codon 1062, are recommended to undergo annual thyroid ultrasound and UGIE screening.
The literature regarding gastric and duodenal manifestations is controversial. Ficari et al stress the relevance of codon 1395 18 while other studies describe abnormalities related to pathogenic variants in codons 564-1465 19 Carriers of variants in codon 934 are at high risk for gastric, duodenal, and papillary adenomas and the development of neoplasms. 20 Bertario et al found gastric and duodenal adenomas in carriers of variants in codons 976-1067. 18, 20 In this study, we 19, 20 In contrast to our results that were consistent with previous reports, our findings from this study regarding desmoid tumors diverge substantially from the literature. According to Caspari et al, 15 Most of the correlations identified in this study were similar to those reported in the literature, but a few atypical cases were noted. Some pathogenic variants require stricter patient monitoring, such as variants involving codons 232, 805, 986, 1062, 1104, 1166, and 1309 since they were related to CRC and associated tumors such as gastric cancer, brain cancer, and desmoid tumors. For the testing protocol used in this study, patients not subjected to prophylactic surgery should undergo annual colonoscopy with resection of 
| CONCLUSION
Among Brazilian patients with FAP, the genotype-phenotype correlation exhibited specific characteristics not reported for other cohorts. This fact underscores the importance of a thorough knowledge for specific populations regarding pathogenic variants in APC together with the clinical presentation of disease. The application of this type of information in the planning and defining of management strategies for preventive testing might allow for more adequate clinical outcomes.
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